Loco-regional treatment (LRT) for M1 at diagnosis prostate cancer (PCa) patients (pts) and impact on overall survival (OS): A retrospective analysis.

Authors

null

Diletta Bianchini

The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom

Diletta Bianchini , David Lorente Estelles , Pasquale Rescigno , Hazel 'O Sullivan , Michael Paul Kolinsky , Semini Sumanasuriya , Zafeiris Zafeiriou , Niven Mehra , Anurhada Jayaram , Joaquin Mateo , Raquel Perez , Nina Tunariu , Nicholas John Van As , Vincent Khoo , Alison Tree , Chris C. Parker , Rosalind Eeles , David P. Dearnaley , Gerhardt Attard , Johann S. De Bono

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 280)

DOI

10.1200/jco.2016.34.2_suppl.280

Abstract #

280

Poster Bd #

M7

Abstract Disclosures

Similar Posters

Poster

2020 Genitourinary Cancers Symposium

Prostate-directed radiation therapy and overall survival for men with M1a prostate cancer.

Prostate-directed radiation therapy and overall survival for men with M1a prostate cancer.

First Author: David Dewei Yang

Poster

2015 Genitourinary Cancers Symposium

The impact of time to metastasis on survival in treatment-naïve prostate cancer patients.

The impact of time to metastasis on survival in treatment-naïve prostate cancer patients.

First Author: Shusuke Akamatsu

Poster

2024 ASCO Genitourinary Cancers Symposium

Impact of exposure to clinical trials and standard-of-care therapy in metastatic or recurrent prostate cancer: An update.

Impact of exposure to clinical trials and standard-of-care therapy in metastatic or recurrent prostate cancer: An update.

First Author: Grace G Kim

First Author: Edward Christopher Dee